NORTHERN TRUST CORP

Bank

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 73124 CHICAGO, IL

Position in IKT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,783,526

+$575,943 QoQ

Shares Held

878,585

+22.2% QoQ

Ownership

0.630%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 105 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 98% Shared 2% None 0%

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. IKT ranks #237 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,486,478	$1,235,108,212
2	REGN	Regeneron Pharmaceuticals, Inc.	916,467	$571,453,829
3	ALNY	Alnylam Pharmaceuticals, Inc.	886,900	$266,983,504
4	RPRX	Royalty Pharma plc	4,718,859	$264,586,419
5	RVMD	Revolution Medicines, Inc.	1,117,110	$209,212,357
6	MRNA	Moderna, Inc.	2,985,329	$209,062,587
7	INCY	Incyte Corp	1,761,966	$199,736,460
8	CYTK	Cytokinetics Inc	1,647,345	$140,337,319

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,783,526	878,585	+22.2%	Shares	Other	2026-08-13
2026-03-31	$1,207,583	718,800	+122.7%	Shares	Defined	2026-05-14
2025-12-31	$661,574	322,720	-13.8%	Shares	Other	2026-02-17
2025-09-30	$606,423	374,336	-4.7%	Shares	Other	2025-11-14
2025-06-30	$765,795	392,716	+513.5%	Shares	Other	2025-08-13
2025-03-31	$140,184	64,011	0.0%	Shares	Defined	2025-05-13
2024-12-31	$208,035	64,011	+121.7%	Shares	Defined	2025-02-14
2023-03-31	$18,997	28,872	0.0%	Shares	Defined	2023-05-15
2022-12-31	$14,436	28,872	0.0%	Shares	Defined	2023-02-13
2022-09-30	$26,273	28,872	0.0%	Shares	Defined	2022-11-14
2022-06-30	$21,451	28,872	0.0%	Shares	Defined	2022-08-12
2022-03-31	$42,730	28,872	0.0%	Shares	Defined	2022-05-13
2021-12-31	$42,441	28,872	+83.7%	Shares	Defined	2022-02-08
2021-09-30	$29,856	15,714	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.